Aliki Peletidi1, Shereen Nabhani-Gebara, Reem Kayyali. Show Affiliations » 1. School of Pharmacy and Chemistry, Kingston University, London, UK.
Abstract
Mesh: See more » Cost-Benefit AnalysisHumansPatient Education as TopicPharmaciesSmoking/adverse effectsSmoking/economicsSmoking Cessation/economicsSmoking Cessation/methodsTobacco Use Cessation Devices/economicsUnited Kingdom
Year: 2016 PMID: 26856195 DOI: 10.1016/s1109-9666(16)30012-4
Source DB: PubMed Journal: Hellenic J Cardiol ISSN: 1109-9666